MAIA Biotechnology, Inc. (MAIA)
Data as of , from SEC Form 4 filings.
Net insider buying (90d)Watch MAIA
See up to 3 months of MAIA. The 7-day demo opens the 1M and 3M ranges and puts MAIA on your watchlist.
Start 7-day demoLatest MAIA insider trades
- Vlad Vitoc - OfficerOpen-market purchase$100K
Ramiro Guerrero - DirectorOpen-market purchase$50K
About MAIA Biotechnology, Inc. (MAIA)
The SEC lists MAIA Biotechnology, Inc. under CIK 0001878313, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
MAIA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 7 | 258,078 | $352K |
| Grant or award | 6 | 208,839 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
MAIA insider transactions (Form 4)
3975 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jean-Manasse Theagene - Director | Grant or award | Stock Options | 27,258 | $0.00 | - | |
 Stan Smith - Director | Grant or award | Stock Options | 33,099 | $0.00 | - | |
| Stan Smith - Director | Open-market purchase | Common Stock | 2,700 | $3.69 | $10K | |
| Stan Smith - Director | Gift | Common Stock | 20,000 footnote F2 | $0.00 | - | |
| ||||||
| Jean-Manasse Theagene - Director | Grant or award | Options | 24,060 | $0.00 | - | |
| Stan Smith - Director | Grant or award | Options | 29,216 | $0.00 | - | |
 Cristian Luput - Director | Grant or award | Options | 25,206 | $0.00 | - | |
 Ngar Yee Louie - Director | Grant or award | Options | 29,789 | $0.00 | - | |
| Ramiro Guerrero - Director | Grant or award | Options | 24,060 | $0.00 | - | |
| Steven M. Chaouki - Director | Grant or award | Options | 24,633 | $0.00 | - | |
| Stan Smith - Director | Open-market purchase | Common Stock | 57,189 footnote F1 | $1.22 | $70K | |
| Stan Smith - Director | Open-market purchase | Stock Options | 57,189 footnote F6 | $1.36 | $78K | |
| ||||||
| Steven M. Chaouki - Director | Open-market purchase | Common Stock | 40,849 footnote F1 | $1.22 | $50K | |
| Steven M. Chaouki - Director | Open-market purchase | Stock Options | 40,849 footnote F2 | $1.36 | $56K | |
| ||||||
| Ngar Yee Louie - Director | Open-market purchase | Common Stock | 81,699 footnote F1 | $1.22 | $100K | |
| Ngar Yee Louie - Director | Open-market purchase | Stock Options | 81,699 footnote F2 | $1.36 | $111K | |
| ||||||
| Vlad Vitoc - Officer | Open-market purchase | Common Stock | 50,000 | $1.14 footnote F1 | $57K | |
| Vlad Vitoc - Officer | Open-market purchase | Common Stock | 22,000 | $1.05 footnote F2 | $23K | |
| ||||||
| Cristian Luput - Director | Open-market purchase | Common Stock | 20,000 | $1.08 | $22K | |
| Cristian Luput - Director | Open-market purchase | Common Stock | 18,145 | $1.11 footnote F1 | $20K | |
| ||||||
| Stan Smith - Director | Open-market purchase | Common Stock | 15,000 | $1.04 footnote F1 | $16K | |
| ||||||
| Cristian Luput - Director | Open-market purchase | Common Stock | 10,000 | $0.98 | $10K | |
| Vlad Vitoc - Officer | Open-market purchase | Common Stock | 10,500 | $0.97 footnote F1 | $10K | |
| ||||||
| Stan Smith - Director | Open-market purchase | Common Stock | 10,000 | $0.99 footnote F1 | $10K | |
| Stan Smith - Director | Open-market purchase | Common Stock | 15,000 | $0.98 footnote F3 | $15K | |
| ||||||
| Vlad Vitoc - Officer | Open-market purchase | Common Stock | 10,000 | $0.99 | $10K | |
| Vlad Vitoc - Officer | Open-market purchase | Common Stock | 1,800 | $0.92 footnote F1 | $2K | |
| ||||||
| Stan Smith - Director | Open-market purchase | Common Stock | 19,230 footnote F1 | $1.30 | $25K | |
| Stan Smith - Director | Open-market purchase | Warrants | 19,230 footnote F3 | $1.57 | $30K | |
| ||||||
| Stan Smith - Director | Grant or award | Stock Options | 24,844 | $0.00 | - | |
| Jean-Manasse Theagene - Director | Grant or award | Stock Options | 20,459 | $0.00 | - | |
| Cristian Luput - Director | Grant or award | Stock Options | 21,434 | $0.00 | - | |
| Ngar Yee Louie - Director | Grant or award | Stock Options | 25,331 | $0.00 | - | |
| Ramiro Guerrero - Director | Grant or award | Stock Options | 20,459 | $0.00 | - | |
| Steven M. Chaouki - Director | Grant or award | Stock Options | 20,946 | $0.00 | - | |
| Ngar Yee Louie - Director | Grant or award | Stock Options | 25,232 | $0.00 | - | |
| Ramiro Guerrero - Director | Grant or award | Stock Options | 20,380 | $0.00 | - | |
| Jean-Manasse Theagene - Director | Grant or award | Stock Options | 20,380 | $0.00 | - | |
| Stan Smith - Director | Grant or award | Stock Options | 24,747 | $0.00 | - | |
Item 7.01, 9.01
Item 5.07
Item 1.02
Item 8.01, 9.01
MAIA insider trading FAQ
What is the latest insider trade for MAIA?
MAIA Biotechnology, Inc. (MAIA) had 11 insider filings in the last 90 days, with the most recent on 2026-10-02. The full record for MAIA runs to 75 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MAIA stock?
7 insider purchases of MAIA were filed in the last 90 days, totaling $352K.
How many insiders are selling MAIA stock?
No insider sales of MAIA were filed in the last 90 days.
Where can I see MAIA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MAIA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jean-Manasse Theagene view on EDGAR
- - Stan Smith view on EDGAR
- - Cristian Luput view on EDGAR
- - Ngar Yee Louie view on EDGAR
- - Ramiro Guerrero view on EDGAR
- - Steven M. Chaouki view on EDGAR
- - Vlad Vitoc view on EDGAR
- - Ramiro Guerrero view on EDGAR
- - Ramiro Guerrero view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where MAIA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MAIA with a 7-day demo
- MAIA on your watchlist
- Every MAIA Form 4 filing on record
- Up to 3 months of MAIA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
